Tristel plc (AIM:TSTL)

Market Cap	169.50M
Revenue (ttm)	46.46M
Net Income (ttm)	6.64M
Shares Out	47.75M
EPS (ttm)	0.14
PE Ratio	25.67
Forward PE	20.58
Dividend	0.14 (3.86%)
Ex-Dividend Date	Nov 27, 2025

Volume	122,955
Average Volume	152,443
Open	365.00
Previous Close	368.00
Day's Range	351.33 - 370.00
52-Week Range	260.00 - 444.25
Beta	0.23
RSI	40.34
Earnings Date	Nov 25, 2025

About Tristel

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments, Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers device decontamination products, including wipes system, ULT, OPH, Stella system, fuse for Stella, rinse assure, clean, EVE, medistel, EVA system, daisygrip, fuse for surfaces, dosing system, airstel, enzystel, DOK, pre-clean wipes, rinse wip...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1993
• Employees: 267
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: TSTL

Financial Performance

In 2025, Tristel's revenue was 46.46 million, an increase of 10.80% compared to the previous year's 41.93 million. Earnings were 6.64 million, an increase of 2.33%.